Locations:

Research

May 23, 2017/Cancer/Research

A New Strategy for Cancer Treatments

Moving from whack-a-mole to chess

May 8, 2017/Cancer/Research

Promising New Combination Therapy for Advanced, HER2+ Breast Cancer Shown Safe and Effective

Neratinib and trastuzumab emtansine (T-DM1) combination potent and well tolerated

March 15, 2017/Cancer/Research

Cleveland Clinic Researcher Receives $5.5 Million Outstanding Investigator Award

Maciejewski honored for work in bone marrow failure syndromes

February 27, 2017/Cancer/Research

Multigene Panel Testing Reveals Mutations in Early Onset CRC Patients

Results suggest: Offer broad testing to all of them

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

February 23, 2017/Cancer/Research

Sunitinib Treatment Breaks Feasible for Metastatic Renal Cell Carcinoma

Clinical efficacy uncompromised in previously untreated patients

February 6, 2017/Cancer/Research

Promise of PARP Inhibitors for BRCA1/BRCA2 Cancers

Clinical trials testing olaparib in breast cancer

January 20, 2017/Cancer/Research

February Cancer Clinical Trials

Learn about featured cancer clinical trials currently enrolling, or search our cancer clinical trials database for all open and accruing studies

January 16, 2017/Cancer/Research

Researchers Discover How Glioblastoma Stem Cells Evade the Immune System

Finding has potential to improve treatment

December 5, 2016/Cancer/Research

Vadastuximab for AML: Investigator Predicts Changes to Standard Therapy in Near Future

Drug targets CD33 to produce high remission rates

December 3, 2016/Cancer/Research

Novel Drug Regimen Shows Promise for Sickle Cell Disease

Trial results reported for first molecularly targeted therapy

BackPage 29 of 31Next